Pyrotech Therapeutics ("Pyrotech" or the "Company"), a clinical-stage biopharmaceutical company pioneering innate immune modulation and pyroptosis-targeted therapies, announced that the first healthy ...

Alumis (ALMS) stock plummeted 56% after Phase 2b lupus trial failure. IFNGS-high subgroup showed promise. Psoriasis NDA filing still planned for Q4 2026.

A new form of proton therapy-designed to deliver cancer-killing radiation therapy in less than a second, through fewer total ...

Eli Lilly has once again returned to the M&A table, striking a $2.875bn agreement to buy autoimmune and allergic disease drug ...

CERN quantum sensing dark matter researchers launched a two-week institute on August 31 to build a roadmap for detecting dark ...

The battlefield has gone silent — but not because the fighting has stopped. Across the electromagnetic spectrum, an invisible ...

G embeds artificial intelligence directly into network infrastructure, changing wireless validation and performance testing ...

Belgian beanless coffee startup Koppie has launched OtherKinds, a consumer brand of filter coffee and lattes, as a testbed ...

Researchers found that the distance the eye travels during a rapid gaze shift changes post-saccadic visual sensitivity by ...

OliX Pharmaceuticals filed a U.S. patent for a circular mRNA manufacturing platform, extending its RNA technology into ...

A research group in Japan has demonstrated a world-record 10-channel multiplexed quantum photonic interface based on an ...

This manuscript examines how overexpression of sphingosine 1-phosphate receptor 1 in a mouse model affects neutrophil distribution, metabolism and function. Given the significance of S1PR1 in ...